WHAT IS THE BBDRISK DX^® TEST?

The BBDRisk Dx^® Test is a tumor biology based multimarker test that predicts the likelihood of developing breast cancer with ~ 91% accuracy.  Briefly, the Test

• Assays 4 cancer markers, MMP1, CEACAM6, HYAL1 and HEC1 by immunohistochemistry (IHC) in formalin fixed paraffin embedded (FFPE) tissue which was already removed at the time of biopsy
• Calculates a ‘Cancer Risk Score’, based on the marker levels, from 0-10 with higher scores corresponding to higher risk of subsequent cancer development
• Classifies a patient based on the risk score as:
  ‘Low Risk’ (Score <0.5),
  ‘Intermediate Risk’ (Score > 0.5 and ≤ 5.4) or
  ‘High Risk’ (Score >5.4) and finally
• Provides the Cancer Rate for a given Risk Score